Teores de proteína bruta, extrato etéreo e minerais de gramíneas nativas Paspalum repens e Paspalum fasciculatum de ecossistemas de várzea do Baixo Amazonas, Pará, Brasil.

En un Inceptisol húmedos del campo experimental de la Amazonia baja (2°23? de latitud sur y 54°20? de longitud oeste, municipio de Monte Alegre, Pará, Brasil) de la Empresa Brasileira de Pesquisa Agropecuária (Embrapa-Amazonia Oriental), en julio de 2003 (final del período lluvioso), septiembre de 2003 (período seco) y enero de 2004 (comienzo del período lluvioso) se determinaron los contenido de proteína cruda (PC), estracto etereo (EE) y minerales en el forraje de Paspalum repens (Perimembeca) e Paspalum fasciculatum (Mori) procedentes de la zona de varzea. Se utilizó un factorial de dos (especies nativas de forraje) y tres épocas de crecimiento (final y comienzo del periodo lluviosa y época seca). Se encontraron diferencias (P < 0.05) para el contenido de PC de las especies, siendo más alto en Perimembeca (12.06%) que en Mori (6.65). El contenido de P en ambas gramíneas fue bajo. El contenido de Cu en la gramínea Mori fue adecuado en tanto épocas secas como húmedas. Los contenidos de Ca, K y Fe fueron bajos e influenciados por la época

Degradabilidade "in situ" da gramínea nativa Paspalum repens (Perimembeca) de vázea do Baixo Amazonas, Pará.

Zootec 2005

International Expert Opinions and Recommendations on the Use of Melatonin in the Treatment of Insomnia and Circadian Sleep Disturbances in Adult Neuropsychiatric Disorders

Introduction: Insomnia and circadian rhythm disorders, such as the delayed sleep phase syndrome, are frequent in psychiatric disorders and their evaluation and management in early stages should be a priority. The aim of this paper was to express recommendations on the use of exogenous melatonin, which exhibits both chronobiotic and sleep-promoting actions, for the treatment of these sleep disturbances in psychiatric disorders. Methods: To this aim, we conducted a systematic review according to PRISMA on the use of melatonin for the treatment of insomnia and circadian sleep disorders in neuropsychiatry. We expressed recommendations for the use of melatonin in psychiatric clinical practice for each disorder using the RAND/UCLA appropriateness method. Results: We selected 41 studies, which included mood disorders, schizophrenia, substance use disorders, attention deficit hyperactivity disorders, autism spectrum disorders, neurocognitive disorders, and delirium; no studies were found for both anxiety and eating disorders. Conclusion: The administration of prolonged release melatonin at 2–10 mg, 1–2 h before bedtime, might be used in the treatment of insomnia symptoms or comorbid insomnia in mood disorders, schizophrenia, in adults with autism spectrum disorders, neurocognitive disorders and during sedative-hypnotics discontinuation. Immediate release melatonin at &lt;1 mg might be useful in the treatment of circadian sleep disturbances of neuropsychiatric disorders

Changes of consultation-liaison psychiatry practice in Italian general hospitals: A comparative 20-year multicenter study

Introduction: Conducted under the auspices of the Italian Society of Consultation Liaison Psychiatry (SIPC) the aim of this study was to describe the characteristics of Consultation Liaison Psychiatry (CLP) activity in Italy (SIPC-2—2018) over the past 20 years by comparing with data from the first Italian nation-wide study (SIPC-1—1998). Methods: We collected data on CLP visits of 3,943 patients from 10 Italian hospitals over a period of 1 year. Data were compared with those from the SIPC-1 1998 study (4,183 participants). Patients were assessed with the same ad hoc 60-item Patient Registration Form recording information from five different areas: Sociodemographic, hospitalization-related, consultation-related, interventions and outcome. Results: Compared with participants from the previous study, SIPC-2-2018 participants were significantly older (d = 0.54) and hospitalized for a longer duration (d = 0.20). The current study detected an increase in the proportion of referrals from surgical wards and for individuals affected by onco-hematologic diseases. Depressive disorders still represented the most frequent psychiatric diagnosis, followed by adjustment and stress disorders and delirium/dementia. Also, CLP psychiatrists prescribed more often antidepressants (Φ = 0.13), antipsychotics (Φ = 0.09), mood stabilizers (Φ = 0.24), and less often benzodiazepines (Φ = 0.07). Conclusion: CLP workload has increased considerably in the past 20 years in Italy, with changes in patient demographic and clinical characteristics. A trend toward increase in medication-based patient management was observed. These findings suggest that the psychiatric needs of patients admitted to the general hospital are more frequently addressed by referring physicians, although Italian CLP services still deserve better organization and autonomy